CAS No. |
171500-79-1 |
|---|---|
中文名称 |
达巴万星 |
英文名称 |
Dalbavancin |
别名 |
Dalbavancin |
标准英文名 |
(2S,3S,4R,5R,6S)-6-(((3S,15R,18R,34R,35S,38S,48R,50aR)-5,31-dichloro-38-((3-(dimethylamino)propyl)carbamoyl)-6,11,34,40,44-pentahydroxy-15-(methylamino)-2,16,36,50,51,59-hexaoxo-42-(((2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-2,3,16,17,18,19,35,36,37,38,48,49,50,50a-tetradecahydro-1H,15H,34H-3,18:35,48-bis(epiminomethano)-20,23:30,33-dietheno-4,8:10,14:25,28:43,47-tetra(metheno)benzo[14,15][1]oxa[7,17]diazacyclotetracosino[4,5-d][1,14]dioxa[6,22]diazacyclooctacosin-56-yl)oxy)-3,4-dihydroxy-5-(10-methylundecanamido)tetrahydro-2H-pyran-2-carboxylic acid |
分子式 |
C88H100Cl2N10O28 |
分子量 |
1816.72 |
精确分子量 |
1814.61 |
SMILES |
[H][C@@]12CC3=CC=C(C=C3)OC4=C(C5=CC([C@@](NC([C@@](NC1=O)(C6=C(C(O)=CC(OC7=C(C=CC([C@H](C(N2)=O)NC)=C7)O)=C6)Cl)[H])=O)(C(N[C@@]8(C9=CC(C%10=C([C@@H](C(NCCCN(C)C)=O)NC([C@@](NC8=O)([C@@H](C%11=CC(Cl)=C(C=C%11)O5)O)[H])=O)C=C(C=C%10O[C@H]%12O[C@@H]([C@H]([C@@H]([C@@H]%12O)O)O)CO)O)=C(C=C9)O)[H])=O)[H])=C4)O[C@@H]%13O[C@H](C(O)=O)[C@H]([C@@H]([C@H]%13NC(CCCCCCCCC(C)C)=O)O)O |
标准SMILES |
CC(C)CCCCCCCCC(=O)N[C@H]1[C@@H](O[C@@H]([C@@H](O)[C@@H]1O)C(O)=O)OC1=C2C=C3C=C1OC1C=CC(=CC=1Cl)[C@@H](O)[C@@H]1NC(=O)[C@H](NC(=O)[C@@H]3NC(=O)[C@H]3NC(=O)[C@@H](CC4=CC=C(C=C4)O2)NC(=O)[C@H](NC)C2C=CC(O)=C(C=2)OC2C=C(O)C(Cl)=C3C=2)C2C=CC(O)=C(C=2)C2=C(C=C(O)C=C2O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]2O)[C@H](NC1=O)C(=O)NCCCN(C)C |
用途 |
Dalbavancin is used for the treatment of complicated skin and skin structure infections (cSSSIs), particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA) and β-hemolytic streptococci; it is also effective in treating catheter-related bloodstream infections. Additionally, it exhibits potent in vitro bactericidal activity against a broad range of Gram-positive pathogens, including MRSA, methicillin-sensitive Staphylococcus aureus (MSSA), coagulase-negative staphylococci (CoNS), streptococci, penicillin- and ceftriaxone-resistant Streptococcus pneumoniae, teicoplanin-non-susceptible CoNS, non-vanA vancomycin-resistant enterococci (VRE), and Gram-positive anaerobes. |
InChIKey |
KGPGQDLTDHGEGT-SZUNQUCBSA-N |
|
|
评论 |
|---|